Miromatrix Medical Inc.
MIRO · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $11 | $9 | $8 | $930 |
| % Growth | 31.2% | 6.7% | -99.1% | – |
| Cost of Goods Sold | $125 | $125 | $125 | $125 |
| Gross Profit | -$114 | -$116 | -$117 | $805 |
| % Margin | -1,018.5% | -1,367.7% | -1,466.2% | 86.6% |
| R&D Expenses | $3,506 | $3,621 | $4,392 | $4,734 |
| G&A Expenses | $2,143 | $2,038 | $2,600 | $2,206 |
| SG&A Expenses | $2,143 | $2,038 | $2,600 | $2,206 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $3,015 | $2,951 | $990 | $927 |
| Operating Expenses | $6,521 | $6,572 | $7,982 | $7,867 |
| Operating Income | -$6,635 | -$6,688 | -$8,099 | -$7,061 |
| % Margin | -59,369.1% | -78,530.1% | -101,478.9% | -759% |
| Other Income/Exp. Net | $181 | $158 | $619 | $234 |
| Pre-Tax Income | -$6,454 | -$6,530 | -$7,480 | -$6,946 |
| Tax Expense | $0 | $0 | -$290 | $0 |
| Net Income | -$6,454 | -$6,530 | -$7,190 | -$6,946 |
| % Margin | -57,746% | -76,675.1% | -90,091.8% | -746.6% |
| EPS | -0.24 | -0.24 | -0.32 | -0.33 |
| % Growth | 0% | 25% | 3% | – |
| EPS Diluted | -0.24 | -0.24 | -0.32 | -0.33 |
| Weighted Avg Shares Out | 27,314 | 27,251 | 22,508 | 20,907 |
| Weighted Avg Shares Out Dil | 27,314 | 27,251 | 22,508 | 20,907 |
| Supplemental Information | – | – | – | – |
| Interest Income | $197 | $166 | $102 | $128 |
| Interest Expense | $15 | $8 | $10 | $13 |
| Depreciation & Amortization | $288 | $289 | $629 | $128 |
| EBITDA | -$6,150 | -$6,233 | -$6,841 | -$6,933 |
| % Margin | -55,031.4% | -73,180.8% | -85,713.4% | -745.2% |